beta

ABLX

Ablynx NV

Ablx

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

Market Cap: 3.36 Billion

Primary Exchange: Nasdaq Global Select

Website: http://www.ablynx.com

Shares Outstanding: 75.1 Million

Float: 75.1 Million

Dividend: 0.0 (0.0%)

Beta: 14.372817

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 709 Thousand

Ethical Flags

Animal testing

Longest drawdown: 175 trading days

From: 2018-04-18 To: 2018-06-12

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud